Pembrolizumab alone or in combination with chemotherapy as first-line therapy for patients with advanced gastric or gastroesophageal junction adenocarcinoma : results from the phase II nonrandomized KEYNOTE-059 study

dc.contributor.authorBang, Y.J.
dc.contributor.authorKang, Y.K.
dc.contributor.authorCatenacci, D.V.
dc.contributor.authorMuro, K.
dc.contributor.authorFuchs, C.S.
dc.contributor.authorGeva, R.
dc.contributor.authorHara, H.
dc.contributor.authorGolan, T.
dc.contributor.authorGarrido S., Marcelo
dc.contributor.authorJalal, S.I.
dc.contributor.authorBorg, C.
dc.contributor.authorDoi, T.
dc.contributor.authorYoon, H.H.
dc.contributor.authorSavage, M.J.
dc.contributor.authorWang, J.
dc.contributor.authorDalal, R.P.
dc.contributor.authorShah, S.
dc.contributor.authorWainberg, Z.A.
dc.contributor.authorChung, H.C.
dc.date.accessioned2021-05-31T03:47:24Z
dc.date.available2021-05-31T03:47:24Z
dc.date.issued2019
dc.format.extent10 páginas
dc.fuente.origenConveris
dc.identifier.doi10.1007/s10120-018-00909-5
dc.identifier.eissn1436-3305
dc.identifier.issn1436-3291
dc.identifier.urihttps://doi.org/10.1007/s10120-018-00909-5
dc.identifier.urihttps://repositorio.uc.cl/handle/11534/60298
dc.identifier.wosidWOS:000471727400019
dc.issue.numeroNo. 4
dc.language.isoen
dc.nota.accesoContenido completo
dc.pagina.final837
dc.pagina.inicio828
dc.revistaGastric Canceres_ES
dc.rightsacceso abierto
dc.subject.ddc610
dc.subject.deweyMedicina y saludes_ES
dc.subject.ods03 Good health and well-being
dc.subject.odspa03 Salud y bienestar
dc.subject.otherAdenocarcinoma - Tratamiento farmacológicoes_ES
dc.subject.otherNeoplasias esofágicases_ES
dc.titlePembrolizumab alone or in combination with chemotherapy as first-line therapy for patients with advanced gastric or gastroesophageal junction adenocarcinoma : results from the phase II nonrandomized KEYNOTE-059 studyes_ES
dc.typeartículo
dc.volumenVol. 22
sipa.codpersvinculados7260
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Pembrolizumab alone or in combination with chemotherapy as first-line therapy for patients with advanced gastric or gastroesophageal.pdf
Size:
641.16 KB
Format:
Adobe Portable Document Format
Description: